CJC-1295 with DAC is a modified GHRH(1-29) analog carrying a Drug Affinity Complex that binds circulating albumin.
Mechanism of Action:
Activates pituitary GHRH receptors; albumin binding through the DAC linker greatly extends half-life compared with unmodified analogs.
Research Applications:
- GHRH receptor pharmacology
- Extended-exposure pharmacokinetic models
- Comparison with non-DAC analogs
For laboratory research use only. Not for human or animal consumption.
CJC-1295 with DAC at a glance
| Compound type | GHRH(1-29) analog with Drug Affinity Complex |
|---|---|
| Primary research target | Pituitary GHRH receptor |
| Documentation | Batch-specific Certificate of Analysis (see the COA tab) |
| Supplied for | Laboratory research use only |
Frequently asked questions
What is CJC-1295 with DAC?
CJC-1295 with DAC is a modified GHRH(1-29) analog carrying a Drug Affinity Complex that binds circulating albumin.
What do researchers study CJC-1295 with DAC for?
Activates pituitary GHRH receptors; albumin binding through the DAC linker greatly extends half-life compared with unmodified analogs.
Where can I find the Certificate of Analysis?
In the COA tab on this page. Reports come from independent third-party laboratories, are tied to a specific batch, and carry a verification key that can be checked on the testing lab’s website.
Is CJC-1295 with DAC for human use?
No. Karma Research Peptides supplies CJC-1295 with DAC strictly for in-vitro laboratory research. It is not for human or animal consumption, and we do not provide dosing or human-use guidance.
